Doug S. Hawkins MD

Douglas S. Hawkins, MD, is Associate Hematology/Oncology Division Chief, Associate Director of the Center for Clinical and Translational Research at Seattle Childrens Hospital (SCH), clinician at SCH, and professor at the University of Washington School of Medicine. Hawkins is the principal investigator for COG activity at SCH and chair of the COG Soft Tissue Sarcoma Committee.

He is a steering committee member of several COG committees, including the Soft Tissue Sarcoma, Bone Tumor, and Voting Body. He is also the Chair of the COG Scientific and Discipline Chairs Committee. Dr. Hawkins has focused on clinical research, particularly in the treatment of pediatric sarcomas. He is the COG chair of two clinical trials, one for Ewing sarcoma and another for rhabdomyosarcoma. He is collaborating on a pharmacogenomic study investigating cyclophosphamide metabolism and toxicity, both locally and as part of two COG studies. In addition, he collaborates on the use of FDG PET to assess response and guide treatment in pediatric sarcomas.